YI - 111 Inc logo

111, Inc. operates an integrated online and offline healthcare platform in China, offering B2C and B2B services. It provides pharmacy products, supply chain integration, online consultation, inventory management, and data services to pharmacies and medical professionals.

⚕️ Healthcare NASDAQ Listed 2018 ¥ CNY
$1,000 invested 5 years ago →$55today

Score Overview

1 Year
Score
Net Growth73.98%
Net TrendGrew
Net Income Consistency—
Rev Growth-15.19%
Rev TrendShrank
Revenue Consistency—
5 Years
Score6.7
Net Growth96.31%
Net Trend80%
Net Income Consistency—
Rev Growth48.89%
Rev Trend60%
Revenue Consistency—
All Time
Score
Net Growth95.57%
Net Trend71%
Net Income Consistency
Rev Growth6x
Rev Trend71%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where 111 Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. YI does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 3.07—
1 Year2025-10-22
$ 4.53-32.23%
5 Years2021-10-22
$ 55.70-94.49%
All Time2018-09-12
$ 138.00-97.78%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in CNY

Year
2025¥ 12.21B-¥ 16M¥ 611M
2024¥ 14.40B-¥ 64M¥ 462M
2023¥ 14.94B-¥ 392M¥ 653M
2022¥ 13.51B-¥ 416M¥ 879M
2021¥ 12.42B-¥ 669M¥ 843M
2020¥ 8.20B-¥ 456M¥ 1.48B
2019¥ 3.95B-¥ 499M¥ 613M
IPO2018¥ 1.78B-¥ 380M¥ 1.10B
YI - 111 Inc logo

111 Inc fundamental performance

Between 2020 and 2025, revenue grew from ¥ 8.20B to ¥ 12.21B and net income went from -¥ 456M to -¥ 16M. Revenue increased in 3 of those 5 years; net income in 4.

111 Inc currently holds a 5-year HDB Score of 6.7 out of 10. How the HDB Score is calculated.

Membership

Explore YI with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies